Literature DB >> 24900272

Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor.

Erik Laurini1, Valentina Dal Col1, Maria Grazia Mamolo2, Daniele Zampieri2, Paola Posocco1, Maurizio Fermeglia1, Luciano Vio2, Sabrina Pricl1.   

Abstract

This study presents for the first time the 3D model of the σ1 receptor protein as obtained from homology modeling techniques, shows the applicability of this structure to docking-based virtual screening, defines a computational strategy to optimize the results based on a combination of 3D pharmacophore-based docking and MM/PBSA free energy of binding scoring, and provides evidence that these in silico models and recipes are powerful tools on which virtual screening of new σ1 ligands can be based. In particular, the validation of the applicability of docking-based virtual screening to homology models is of utmost importance, since no crystal structure is available to date for the σ1 receptor, and this missing information still constitutes a major hurdle for a rational ligand design for this important protein target.

Entities:  

Keywords:  3D pharmacophore model; docking; free energy of binding; homology modeling; virtual screening; σ1 Receptor

Year:  2011        PMID: 24900272      PMCID: PMC4017991          DOI: 10.1021/ml2001505

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

1.  Ligand-supported homology modeling of g-protein-coupled receptor sites: models sufficient for successful virtual screening.

Authors:  Andreas Evers; Gerhard Klebe
Journal:  Angew Chem Int Ed Engl       Date:  2004-01       Impact factor: 15.336

Review 2.  Sigma receptors: potential medications development target for anti-cocaine agents.

Authors:  Rae R Matsumoto; Yun Liu; Megan Lerner; Eric W Howard; Daniel J Brackett
Journal:  Eur J Pharmacol       Date:  2003-05-23       Impact factor: 4.432

3.  Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.

Authors:  Andreas Evers; Thomas Klabunde
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

4.  Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.

Authors:  Daniele Zampieri; Maria Grazia Mamolo; Erik Laurini; Caterina Zanette; Chiara Florio; Simona Collina; Daniela Rossi; Ornella Azzolina; Luciano Vio
Journal:  Eur J Med Chem       Date:  2008-03-27       Impact factor: 6.514

5.  Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene.

Authors:  P D Prasad; H W Li; Y J Fei; M E Ganapathy; T Fujita; L H Plumley; T L Yang-Feng; F H Leibach; V Ganapathy
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

Review 6.  The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis.

Authors:  F F Moebius; J Striessnig; H Glossmann
Journal:  Trends Pharmacol Sci       Date:  1997-03       Impact factor: 14.819

7.  Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor.

Authors:  P Seth; M E Ganapathy; S J Conway; C D Bridges; S B Smith; P Casellas; V Ganapathy
Journal:  Biochim Biophys Acta       Date:  2001-07-25

8.  Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening.

Authors:  Christian Laggner; Claudia Schieferer; Birgit Fiechtner; Gloria Poles; Rémy D Hoffmann; Hartmut Glossmann; Thierry Langer; Fabian F Moebius
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

9.  Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1).

Authors:  R Kekuda; P D Prasad; Y J Fei; F H Leibach; V Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  1996-12-13       Impact factor: 3.575

Review 10.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

View more
  13 in total

1.  New consensus multivariate models based on PLS and ANN studies of sigma-1 receptor antagonists.

Authors:  Aline A Oliveira; Célio F Lipinski; Estevão B Pereira; Kathia M Honorio; Patrícia R Oliveira; Karen C Weber; Roseli A F Romero; Alexsandro G de Sousa; Albérico B F da Silva
Journal:  J Mol Model       Date:  2017-10-02       Impact factor: 1.810

2.  The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands.

Authors:  Ashish K Mishra; Timur Mavlyutov; Deo R Singh; Gabriel Biener; Jay Yang; Julie A Oliver; Arnold Ruoho; Valerică Raicu
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

3.  Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3).

Authors:  Lara Brambilla; Davide Genini; Erik Laurini; Jessica Merulla; Laurent Perez; Maurizio Fermeglia; Giuseppina M Carbone; Sabrina Pricl; Carlo V Catapano
Journal:  Mol Oncol       Date:  2015-03-05       Impact factor: 6.603

Review 4.  Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Mahboob Morshed; Naznin Sultana Remex; Md Shenuarin Bhuiyan
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

5.  Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ1 Receptors in the Brain.

Authors:  Katharina Holl; Dirk Schepmann; Steffen Fischer; Friedrich-Alexander Ludwig; Achim Hiller; Cornelius K Donat; Winnie Deuther-Conrad; Peter Brust; Bernhard Wünsch
Journal:  Pharmaceuticals (Basel)       Date:  2014-01-22

6.  Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib.

Authors:  Vittorio Perfetti; Erik Laurini; Suzana Aulić; Maurizio Fermeglia; Roberta Riboni; Marco Lucioni; Elena Dallera; Sara Delfanti; Luigi Pugliese; Francesco Saverio Latteri; Andrea Pietrabissa; Sabrina Pricl
Journal:  Oncotarget       Date:  2017-07-18

7.  β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression.

Authors:  Chiara Colombo; Antonino Belfiore; Nicholas Paielli; Loris De Cecco; Silvana Canevari; Erik Laurini; Maurizio Fermeglia; Sabrina Pricl; Paolo Verderio; Stefano Bottelli; Marco Fiore; Silvia Stacchiotti; Elena Palassini; Alessandro Gronchi; Silvana Pilotti; Federica Perrone
Journal:  Mol Oncol       Date:  2017-09-29       Impact factor: 6.603

8.  Structural Insights into σ₁ Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations.

Authors:  Mateusz Kurciński; Małgorzata Jarończyk; Piotr F J Lipiński; Jan Cz Dobrowolski; Joanna Sadlej
Journal:  Molecules       Date:  2018-02-18       Impact factor: 4.411

9.  New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties.

Authors:  Martín Estrada-Valencia; Clara Herrera-Arozamena; Concepción Pérez; Dolores Viña; José A Morales-García; Ana Pérez-Castillo; Eva Ramos; Alejandro Romero; Erik Laurini; Sabrina Pricl; María Isabel Rodríguez-Franco
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

10.  FRAGSITE: A Fragment-Based Approach for Virtual Ligand Screening.

Authors:  Hongyi Zhou; Hongnan Cao; Jeffrey Skolnick
Journal:  J Chem Inf Model       Date:  2021-03-16       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.